Loading…
Evaluation of N-aryl-β-alanine derivatives as anticancer agents in triple-negative breast cancer and glioblastoma in vitro models
[Display omitted] •β-amino acids derivatives bearing hydrazone and azole moieties was synthesized.•Promising compounds against cancer cell lines contain 4-BrPh or 4-ClPh moieties.•Two selected drug candidates showed migrastatic effect on MDA-MB-231 cell line. Synthesis of β-amino acid derivatives co...
Saved in:
Published in: | Bioorganic chemistry 2021-10, Vol.115, p.105214-105214, Article 105214 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c362t-c7b6e19d5229409695f15014448734e8e9177a198395f9287c40753f93983b383 |
---|---|
cites | cdi_FETCH-LOGICAL-c362t-c7b6e19d5229409695f15014448734e8e9177a198395f9287c40753f93983b383 |
container_end_page | 105214 |
container_issue | |
container_start_page | 105214 |
container_title | Bioorganic chemistry |
container_volume | 115 |
creator | Žukauskas, Mindaugas Grybaitė, Birutė Jonutė, Paulina Vaickelionienė, Rita Gibieža, Paulius Vaickelionis, Giedrius Dragūnaitė, Bertina Anusevičius, Kazimieras Mickevičius, Vytautas Petrikaitė, Vilma |
description | [Display omitted]
•β-amino acids derivatives bearing hydrazone and azole moieties was synthesized.•Promising compounds against cancer cell lines contain 4-BrPh or 4-ClPh moieties.•Two selected drug candidates showed migrastatic effect on MDA-MB-231 cell line.
Synthesis of β-amino acid derivatives containing hydrazone and azole moieties is described. For this purpose, the appropriate hydrazide was treated with aromatic aldehydes, ketones and phenyl iso(thio)cyanates to obtain the desired outcome. The synthesized target compounds were evaluated for their anticancer properties. The assay displayed 3,3′-((2,6-diethylphenyl)azanediyl)bis(N′-(benzylidene)propanehydrazide) to possess the convincing anticancer effect against triple-negative breast cancer cells in vitro. To further study the anticancer properties of compounds containing a hydrazone moiety in breast cancer, series of previously and newly prepared dihydrazones were investigated. It was determined that derivatives with the bis(N′-(4-bromobenzylidene) fragment in the structure are exclusively cytotoxic to cancer cells. The most active compounds against both cell lines were those containing electron withdrawing 4-BrPh or 4-ClPh moieties, together with either chlorine, bromine or iodine groups in para position of phenyl ring. Selected two representative compounds showed migrastatic activity in MDA-MB-231 cell line, where both of them reduced the growth of breast cancer and glioblastoma cell 3D cultures and inhibited cell colony formation. 2009 Elsevier Ltd. All rights reserved. |
doi_str_mv | 10.1016/j.bioorg.2021.105214 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2564131959</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0045206821005915</els_id><sourcerecordid>2564131959</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-c7b6e19d5229409695f15014448734e8e9177a198395f9287c40753f93983b383</originalsourceid><addsrcrecordid>eNp9kM-KFDEQh4Mo7rj6BiI5esmYSqfTnYsgy_oHFr3oOaTT1UOGdDImPQ1efSQfxGcyY-96FAIFVd8vRX2EvAS-Bw7qzXE_-JTyYS-4gNpqBchHZAdccyZA8Mdkx7lsmeCqvyLPSjlyDiA79ZRcNVIKBQp25OftasPZLj5Fmib6mdn8I7Dfv5gNNvqIdMTs1zpfsVBbX1y8s9FhpvaAcSnUR7pkfwrIIh7-gnTIaMtCH7g40kPwaQi1mWZ7Sax-yYnOacRQnpMnkw0FX9zXa_Lt_e3Xm4_s7suHTzfv7phrlFiY6waFoMdWCC25VrqdoOUgpey7RmKPGrrOgu6bOtGi75zkXdtMuqmtoemba_J6-_eU0_czlsXMvjgM9VBM52JEqyQ0oFtdUbmhLqdSMk7mlP1c1Rjg5mLfHM1m31zsm81-jb2633AeZhz_hR50V-DtBtSzcfWYTXEeq6XRZ3SLGZP__4Y_KeaYQw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2564131959</pqid></control><display><type>article</type><title>Evaluation of N-aryl-β-alanine derivatives as anticancer agents in triple-negative breast cancer and glioblastoma in vitro models</title><source>Elsevier</source><creator>Žukauskas, Mindaugas ; Grybaitė, Birutė ; Jonutė, Paulina ; Vaickelionienė, Rita ; Gibieža, Paulius ; Vaickelionis, Giedrius ; Dragūnaitė, Bertina ; Anusevičius, Kazimieras ; Mickevičius, Vytautas ; Petrikaitė, Vilma</creator><creatorcontrib>Žukauskas, Mindaugas ; Grybaitė, Birutė ; Jonutė, Paulina ; Vaickelionienė, Rita ; Gibieža, Paulius ; Vaickelionis, Giedrius ; Dragūnaitė, Bertina ; Anusevičius, Kazimieras ; Mickevičius, Vytautas ; Petrikaitė, Vilma</creatorcontrib><description>[Display omitted]
•β-amino acids derivatives bearing hydrazone and azole moieties was synthesized.•Promising compounds against cancer cell lines contain 4-BrPh or 4-ClPh moieties.•Two selected drug candidates showed migrastatic effect on MDA-MB-231 cell line.
Synthesis of β-amino acid derivatives containing hydrazone and azole moieties is described. For this purpose, the appropriate hydrazide was treated with aromatic aldehydes, ketones and phenyl iso(thio)cyanates to obtain the desired outcome. The synthesized target compounds were evaluated for their anticancer properties. The assay displayed 3,3′-((2,6-diethylphenyl)azanediyl)bis(N′-(benzylidene)propanehydrazide) to possess the convincing anticancer effect against triple-negative breast cancer cells in vitro. To further study the anticancer properties of compounds containing a hydrazone moiety in breast cancer, series of previously and newly prepared dihydrazones were investigated. It was determined that derivatives with the bis(N′-(4-bromobenzylidene) fragment in the structure are exclusively cytotoxic to cancer cells. The most active compounds against both cell lines were those containing electron withdrawing 4-BrPh or 4-ClPh moieties, together with either chlorine, bromine or iodine groups in para position of phenyl ring. Selected two representative compounds showed migrastatic activity in MDA-MB-231 cell line, where both of them reduced the growth of breast cancer and glioblastoma cell 3D cultures and inhibited cell colony formation. 2009 Elsevier Ltd. All rights reserved.</description><identifier>ISSN: 0045-2068</identifier><identifier>EISSN: 1090-2120</identifier><identifier>DOI: 10.1016/j.bioorg.2021.105214</identifier><identifier>PMID: 34426161</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Alanine - analogs & derivatives ; Alanine - chemistry ; Alanine - pharmacology ; Anticancer activity ; Antineoplastic Agents - chemical synthesis ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Azoles ; Cell Line, Tumor ; Cell Proliferation - drug effects ; Cell Survival - drug effects ; Dose-Response Relationship, Drug ; Drug Screening Assays, Antitumor ; Glioblastoma - drug therapy ; Glioblastoma - metabolism ; Glioblastoma - pathology ; Humans ; Hydrazones ; Molecular Structure ; Pyrrolidinones ; Structure-Activity Relationship ; Triple Negative Breast Neoplasms - drug therapy ; Triple Negative Breast Neoplasms - metabolism ; Triple Negative Breast Neoplasms - pathology ; β-Amino acids</subject><ispartof>Bioorganic chemistry, 2021-10, Vol.115, p.105214-105214, Article 105214</ispartof><rights>2021 Elsevier Inc.</rights><rights>Copyright © 2021 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-c7b6e19d5229409695f15014448734e8e9177a198395f9287c40753f93983b383</citedby><cites>FETCH-LOGICAL-c362t-c7b6e19d5229409695f15014448734e8e9177a198395f9287c40753f93983b383</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34426161$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Žukauskas, Mindaugas</creatorcontrib><creatorcontrib>Grybaitė, Birutė</creatorcontrib><creatorcontrib>Jonutė, Paulina</creatorcontrib><creatorcontrib>Vaickelionienė, Rita</creatorcontrib><creatorcontrib>Gibieža, Paulius</creatorcontrib><creatorcontrib>Vaickelionis, Giedrius</creatorcontrib><creatorcontrib>Dragūnaitė, Bertina</creatorcontrib><creatorcontrib>Anusevičius, Kazimieras</creatorcontrib><creatorcontrib>Mickevičius, Vytautas</creatorcontrib><creatorcontrib>Petrikaitė, Vilma</creatorcontrib><title>Evaluation of N-aryl-β-alanine derivatives as anticancer agents in triple-negative breast cancer and glioblastoma in vitro models</title><title>Bioorganic chemistry</title><addtitle>Bioorg Chem</addtitle><description>[Display omitted]
•β-amino acids derivatives bearing hydrazone and azole moieties was synthesized.•Promising compounds against cancer cell lines contain 4-BrPh or 4-ClPh moieties.•Two selected drug candidates showed migrastatic effect on MDA-MB-231 cell line.
Synthesis of β-amino acid derivatives containing hydrazone and azole moieties is described. For this purpose, the appropriate hydrazide was treated with aromatic aldehydes, ketones and phenyl iso(thio)cyanates to obtain the desired outcome. The synthesized target compounds were evaluated for their anticancer properties. The assay displayed 3,3′-((2,6-diethylphenyl)azanediyl)bis(N′-(benzylidene)propanehydrazide) to possess the convincing anticancer effect against triple-negative breast cancer cells in vitro. To further study the anticancer properties of compounds containing a hydrazone moiety in breast cancer, series of previously and newly prepared dihydrazones were investigated. It was determined that derivatives with the bis(N′-(4-bromobenzylidene) fragment in the structure are exclusively cytotoxic to cancer cells. The most active compounds against both cell lines were those containing electron withdrawing 4-BrPh or 4-ClPh moieties, together with either chlorine, bromine or iodine groups in para position of phenyl ring. Selected two representative compounds showed migrastatic activity in MDA-MB-231 cell line, where both of them reduced the growth of breast cancer and glioblastoma cell 3D cultures and inhibited cell colony formation. 2009 Elsevier Ltd. All rights reserved.</description><subject>Alanine - analogs & derivatives</subject><subject>Alanine - chemistry</subject><subject>Alanine - pharmacology</subject><subject>Anticancer activity</subject><subject>Antineoplastic Agents - chemical synthesis</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Azoles</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation - drug effects</subject><subject>Cell Survival - drug effects</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Screening Assays, Antitumor</subject><subject>Glioblastoma - drug therapy</subject><subject>Glioblastoma - metabolism</subject><subject>Glioblastoma - pathology</subject><subject>Humans</subject><subject>Hydrazones</subject><subject>Molecular Structure</subject><subject>Pyrrolidinones</subject><subject>Structure-Activity Relationship</subject><subject>Triple Negative Breast Neoplasms - drug therapy</subject><subject>Triple Negative Breast Neoplasms - metabolism</subject><subject>Triple Negative Breast Neoplasms - pathology</subject><subject>β-Amino acids</subject><issn>0045-2068</issn><issn>1090-2120</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kM-KFDEQh4Mo7rj6BiI5esmYSqfTnYsgy_oHFr3oOaTT1UOGdDImPQ1efSQfxGcyY-96FAIFVd8vRX2EvAS-Bw7qzXE_-JTyYS-4gNpqBchHZAdccyZA8Mdkx7lsmeCqvyLPSjlyDiA79ZRcNVIKBQp25OftasPZLj5Fmib6mdn8I7Dfv5gNNvqIdMTs1zpfsVBbX1y8s9FhpvaAcSnUR7pkfwrIIh7-gnTIaMtCH7g40kPwaQi1mWZ7Sax-yYnOacRQnpMnkw0FX9zXa_Lt_e3Xm4_s7suHTzfv7phrlFiY6waFoMdWCC25VrqdoOUgpey7RmKPGrrOgu6bOtGi75zkXdtMuqmtoemba_J6-_eU0_czlsXMvjgM9VBM52JEqyQ0oFtdUbmhLqdSMk7mlP1c1Rjg5mLfHM1m31zsm81-jb2633AeZhz_hR50V-DtBtSzcfWYTXEeq6XRZ3SLGZP__4Y_KeaYQw</recordid><startdate>202110</startdate><enddate>202110</enddate><creator>Žukauskas, Mindaugas</creator><creator>Grybaitė, Birutė</creator><creator>Jonutė, Paulina</creator><creator>Vaickelionienė, Rita</creator><creator>Gibieža, Paulius</creator><creator>Vaickelionis, Giedrius</creator><creator>Dragūnaitė, Bertina</creator><creator>Anusevičius, Kazimieras</creator><creator>Mickevičius, Vytautas</creator><creator>Petrikaitė, Vilma</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202110</creationdate><title>Evaluation of N-aryl-β-alanine derivatives as anticancer agents in triple-negative breast cancer and glioblastoma in vitro models</title><author>Žukauskas, Mindaugas ; Grybaitė, Birutė ; Jonutė, Paulina ; Vaickelionienė, Rita ; Gibieža, Paulius ; Vaickelionis, Giedrius ; Dragūnaitė, Bertina ; Anusevičius, Kazimieras ; Mickevičius, Vytautas ; Petrikaitė, Vilma</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-c7b6e19d5229409695f15014448734e8e9177a198395f9287c40753f93983b383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Alanine - analogs & derivatives</topic><topic>Alanine - chemistry</topic><topic>Alanine - pharmacology</topic><topic>Anticancer activity</topic><topic>Antineoplastic Agents - chemical synthesis</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Azoles</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation - drug effects</topic><topic>Cell Survival - drug effects</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Screening Assays, Antitumor</topic><topic>Glioblastoma - drug therapy</topic><topic>Glioblastoma - metabolism</topic><topic>Glioblastoma - pathology</topic><topic>Humans</topic><topic>Hydrazones</topic><topic>Molecular Structure</topic><topic>Pyrrolidinones</topic><topic>Structure-Activity Relationship</topic><topic>Triple Negative Breast Neoplasms - drug therapy</topic><topic>Triple Negative Breast Neoplasms - metabolism</topic><topic>Triple Negative Breast Neoplasms - pathology</topic><topic>β-Amino acids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Žukauskas, Mindaugas</creatorcontrib><creatorcontrib>Grybaitė, Birutė</creatorcontrib><creatorcontrib>Jonutė, Paulina</creatorcontrib><creatorcontrib>Vaickelionienė, Rita</creatorcontrib><creatorcontrib>Gibieža, Paulius</creatorcontrib><creatorcontrib>Vaickelionis, Giedrius</creatorcontrib><creatorcontrib>Dragūnaitė, Bertina</creatorcontrib><creatorcontrib>Anusevičius, Kazimieras</creatorcontrib><creatorcontrib>Mickevičius, Vytautas</creatorcontrib><creatorcontrib>Petrikaitė, Vilma</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Žukauskas, Mindaugas</au><au>Grybaitė, Birutė</au><au>Jonutė, Paulina</au><au>Vaickelionienė, Rita</au><au>Gibieža, Paulius</au><au>Vaickelionis, Giedrius</au><au>Dragūnaitė, Bertina</au><au>Anusevičius, Kazimieras</au><au>Mickevičius, Vytautas</au><au>Petrikaitė, Vilma</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of N-aryl-β-alanine derivatives as anticancer agents in triple-negative breast cancer and glioblastoma in vitro models</atitle><jtitle>Bioorganic chemistry</jtitle><addtitle>Bioorg Chem</addtitle><date>2021-10</date><risdate>2021</risdate><volume>115</volume><spage>105214</spage><epage>105214</epage><pages>105214-105214</pages><artnum>105214</artnum><issn>0045-2068</issn><eissn>1090-2120</eissn><abstract>[Display omitted]
•β-amino acids derivatives bearing hydrazone and azole moieties was synthesized.•Promising compounds against cancer cell lines contain 4-BrPh or 4-ClPh moieties.•Two selected drug candidates showed migrastatic effect on MDA-MB-231 cell line.
Synthesis of β-amino acid derivatives containing hydrazone and azole moieties is described. For this purpose, the appropriate hydrazide was treated with aromatic aldehydes, ketones and phenyl iso(thio)cyanates to obtain the desired outcome. The synthesized target compounds were evaluated for their anticancer properties. The assay displayed 3,3′-((2,6-diethylphenyl)azanediyl)bis(N′-(benzylidene)propanehydrazide) to possess the convincing anticancer effect against triple-negative breast cancer cells in vitro. To further study the anticancer properties of compounds containing a hydrazone moiety in breast cancer, series of previously and newly prepared dihydrazones were investigated. It was determined that derivatives with the bis(N′-(4-bromobenzylidene) fragment in the structure are exclusively cytotoxic to cancer cells. The most active compounds against both cell lines were those containing electron withdrawing 4-BrPh or 4-ClPh moieties, together with either chlorine, bromine or iodine groups in para position of phenyl ring. Selected two representative compounds showed migrastatic activity in MDA-MB-231 cell line, where both of them reduced the growth of breast cancer and glioblastoma cell 3D cultures and inhibited cell colony formation. 2009 Elsevier Ltd. All rights reserved.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>34426161</pmid><doi>10.1016/j.bioorg.2021.105214</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0045-2068 |
ispartof | Bioorganic chemistry, 2021-10, Vol.115, p.105214-105214, Article 105214 |
issn | 0045-2068 1090-2120 |
language | eng |
recordid | cdi_proquest_miscellaneous_2564131959 |
source | Elsevier |
subjects | Alanine - analogs & derivatives Alanine - chemistry Alanine - pharmacology Anticancer activity Antineoplastic Agents - chemical synthesis Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology Azoles Cell Line, Tumor Cell Proliferation - drug effects Cell Survival - drug effects Dose-Response Relationship, Drug Drug Screening Assays, Antitumor Glioblastoma - drug therapy Glioblastoma - metabolism Glioblastoma - pathology Humans Hydrazones Molecular Structure Pyrrolidinones Structure-Activity Relationship Triple Negative Breast Neoplasms - drug therapy Triple Negative Breast Neoplasms - metabolism Triple Negative Breast Neoplasms - pathology β-Amino acids |
title | Evaluation of N-aryl-β-alanine derivatives as anticancer agents in triple-negative breast cancer and glioblastoma in vitro models |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T11%3A22%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20N-aryl-%CE%B2-alanine%20derivatives%20as%20anticancer%20agents%20in%20triple-negative%20breast%20cancer%20and%20glioblastoma%20in%20vitro%20models&rft.jtitle=Bioorganic%20chemistry&rft.au=%C5%BDukauskas,%20Mindaugas&rft.date=2021-10&rft.volume=115&rft.spage=105214&rft.epage=105214&rft.pages=105214-105214&rft.artnum=105214&rft.issn=0045-2068&rft.eissn=1090-2120&rft_id=info:doi/10.1016/j.bioorg.2021.105214&rft_dat=%3Cproquest_cross%3E2564131959%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c362t-c7b6e19d5229409695f15014448734e8e9177a198395f9287c40753f93983b383%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2564131959&rft_id=info:pmid/34426161&rfr_iscdi=true |